Understanding antimicrobial pharmacokinetics in critically ill patients to optimize antimicrobial therapy: A narrative review

被引：3
作者：
Roger, Claire [1 ,2 ]
机构：
[1] Nimes Caremeau Univ Hosp, Dept Anesthesiol & Intens Care Pain & Emergency Me, Pl Prof Robert Debre, F-30029 Nimes 9, France
[2] Montpellier Univ, Fac Med, UR IMAGINE Initial Management & Prevent OrGan Fail, Montpellier, France
来源：
JOURNAL OF INTENSIVE MEDICINE | 2024年 / 4卷 / 03期
关键词：
Pharmacokinetics/pharmacodynamics; ICU; Antibiotics; Dose optimization; TDM; AUGMENTED RENAL CLEARANCE; CARE-UNIT PATIENTS; CEFEPIME PLASMA-CONCENTRATIONS; FEBRILE NEUTROPENIC PATIENTS; BETA-LACTAM ANTIBIOTICS; TARGET SITE PENETRATION; CONTINUOUS-INFUSION; POPULATION PHARMACOKINETICS; COLISTIN METHANESULFONATE; INTRAVENOUS FOSFOMYCIN;
D O I：
10.1016/j.jointm.2023.12.007
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
Effective treatment of sepsis not only demands prompt administration of appropriate antimicrobials but also requires precise dosing to enhance the likelihood of patient survival. Adequate dosing refers to the administration of doses that yield therapeutic drug concentrations at the infection site. This ensures a favorable clinical and microbiological response while avoiding antibiotic-related toxicity. Therapeutic drug monitoring (TDM) is the recommended approach for attaining these goals. However, TDM is not universally available in all intensive care units (ICUs) and for all antimicrobial agents. In the absence of TDM, healthcare practitioners need to rely on several factors to make informed dosing decisions. These include the patient's clinical condition, causative pathogen, impact of organ dysfunction (requiring extracorporeal therapies), and physicochemical properties of the antimicrobials. In this context, the pharmacokinetics of antimicrobials vary considerably between different critically ill patients and within the same patient over the course of ICU stay. This variability underscores the need for individualized dosing. This review aimed to describe the main pathophysiological changes observed in critically ill patients and their impact on antimicrobial drug dosing decisions. It also aimed to provide essential practical recommendations that may aid clinicians in optimizing antimicrobial therapy among critically ill patients.
引用
收藏
页码：287 / 298
页数：12
相关论文
共 128 条
  • [31] Sinnollareddy M.G., Roberts M.S., Lipman J., Lassig-Smith M., Starr T., Robertson T., Et al., In vivo microdialysis to determine subcutaneous interstitial fluid penetration and pharmacokinetics of fluconazole in intensive care unit patients with sepsis, Antimicrob Agents Chemother, 60, 2, pp. 827-832, (2016)
  • [32] Mouton J.W., Theuretzbacher U., Craig W.A., Tulkens P.M., Derendorf H., Cars O., Tissue concentrations: do we ever learn?, J Antimicrob Chemother, 61, 2, pp. 235-237, (2008)
  • [33] Tegeder I., Schmidtko A., Brautigam L., Kirschbaum A., Geisslinger G., Lotsch J., Tissue distribution of imipenem in critically ill patients, Clin Pharmacol Ther, 71, 5, pp. 325-333, (2002)
  • [34] Viaggi B., Cangialosi A., Langer M., Olivieri C., Gori A., Corona A., Et al., Tissue penetration of antimicrobials in intensive care unit patients: a systematic review-part II, Antibiotics (Basel), 11, 9, (2022)
  • [35] Zeitlinger B.S., Zeitlinger M., Leitner I., Muller M., Joukhadar C., Clinical scoring system for the prediction of target site penetration of antimicrobials in patients with sepsis, Clin Pharmacokinet, 46, 1, pp. 75-83, (2007)
  • [36] Wildschut E.D., Ahsman M.J., Allegaert K., Mathot R.A., Tibboel D., Determinants of drug absorption in different ECMO circuits, Intensive Care Med, 36, 12, pp. 2109-2116, (2010)
  • [37] Park J., Shin D.A., Lee S., Cho Y.J., Jheon S., Lee J.C., Et al., Investigation of key circuit constituents affecting drug sequestration during extracorporeal membrane oxygenation treatment, ASAIO J, 63, 3, pp. 293-298, (2017)
  • [38] Shekar K., Roberts J.A., McDonald C.I., Ghassabian S., Anstey C., Wallis S.C., Et al., Protein-bound drugs are prone to sequestration in the extracorporeal membrane oxygenation circuit: results from an ex vivo study, Crit Care, 19, 1, (2015)
  • [39] Roberts J.A., Bellomo R., Cotta M.O., Koch B.C.P., Lyster H., Ostermann M., Et al., Machines that help machines to help patients: optimising antimicrobial dosing in patients receiving extracorporeal membrane oxygenation and renal replacement therapy using dosing software, Intensive Care Med, 48, 10, pp. 1338-1351, (2022)
  • [40] Shekar K., Roberts J.A., Barnett A.G., Diab S., Wallis S.C., Fung Y.L., Et al., Can physicochemical properties of antimicrobials be used to predict their pharmacokinetics during extracorporeal membrane oxygenation? Illustrative data from ovine models, Crit Care, 19, (2015)
12345678910